AR226-2152 4oO3 t *T--I Ph P S) t o> Ph RP026176 EXD476984 # Steve Swearingen Cathie Barton, DuET Debbie Mulrooney, DuET Tim Bingman, CRG w ow <Ti v] -0 EXD476985 Chronic Off-Site g ii I Purpose: Identify the design parameters required so that the average daily concentration off-site is below the CEG and on-site is less than the AEL - Emission rate - Stack Height - Stack Height/building height ratio - Dilution Air flow Model used: Industrial Source Complex (ISC v.3); a model used by EPA for air toxics permitting Results shown are using RDU meteorology data; FAY data available this week; model results will be updated.

AR226-3122 g a ttm ia * u v 5 a c E W j :i3 ^ g iw v s a ^ mr7BTn;p,'iiaBgT.gncnCTO T fa a y ^ j: CONFIDENTIAL DPT 429/984523/AC ACUTE ORAL TO XICITY TO THE RAT (FIXED DOSE M ETH O D) Sponsor DuPont Speciality Chemicals Jackson Laboratory Chambers Works Deepwater NJ 08023 USA Research Laboratory Huntingdon Life Sciences Ltd P.O.

Vapor Pressure Determination: DuPont report 12735 Test Guideline^) Authors Mary A.

M w- m 485 Accession No.

P-1 3 000043 P-2 2ndD raft Trip Report Visit to National Medical Services Laboratory (NM S) Monday, January 29,2001 Mary A.

CoSlcThLesBteurr,liVngetromnont Extended Data Package SDG: 117633 Case Narrative Chain of Custody................................................................................................

-f\ R o iQ _ o s rs ~ PFOS Pharmacokinetic - 7 000223 C O V iH tfc I ^ the development services company Covane Laboratories Inc.

STL Burlington Colchester, Vermont Extended Data Package SDG: 117591 Case Narrative Sample Report Summary - Geotechnical.........................................................

Aftt26 - 0061 I Centre Analytical Laboratories, frtc.

BACK TO MAIN SANITIZED REPORT EXPLORATORY 28-DAY ORAL TOXICITY STUDY WITH TELOMER ALCOHOL, TELOMER ACRYLATE.

BACK TO MAIN JttStSSbk.

A&8.S.6 - 06D PFOS Repeat Dose - 000066 Pathology Associates International A Company of Science Applications International Corporation An Employee Owned Company Dr.

fifi 8.3.6 _ 0 6 S' PFOS Pharmacokinetic - / 000113 AN INVESTIGATION OF THE EFFECTS OF FLUOROCARBONS ON LIVER FATTY ACID-BINDING PROTEIN.

.s (ra Kha^iiVa .

AR A 6 -- H-ZA TSCA NCIC Notification Form for CB!